Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Alto Neuroscience, Inc. | 10%+ Owner | Common Stock | 3.71M | Feb 6, 2024 | Indirect | ||
Golden Falcon Acquisition Corp. | 10%+ Owner | Class A Common Stock, par value $0.0001 per share | 750K | Dec 27, 2022 | Indirect | ||
Alto Neuroscience, Inc. | 10%+ Owner | Series B Convertible Preferred Stock (Series B Preferred) | 0 | Feb 6, 2024 | Indirect | ||
Alto Neuroscience, Inc. | 10%+ Owner | Series C Convertible Preferred Stock (Series C Preferred) | 0 | Feb 6, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ANRO | Alto Neuroscience, Inc. | Feb 6, 2024 | 5 | $9.6M | 4 | Feb 8, 2024 | 10%+ Owner |
GFX | Golden Falcon Acquisition Corp. | Dec 27, 2022 | 0 | $0 | 3 | Mar 30, 2023 | 10%+ Owner |